Net Income

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

An award for recycling innovation signals a major market shift, as Aurora Material Solutions turns waste PVC into a high-value industrial asset.

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A new memory module may seem obscure, but it’s a key piece of the puzzle for building trusted AI, resilient 5G, and reliable edge computing.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

Hyatt's new safari partnership isn't just a perk; it's a strategic move into purpose-driven travel, redefining luxury loyalty for a new era.

A regulatory filing from Weiss Asset Management reveals a complex arbitrage play on Alphawave IP, spotlighting its critical role in the Qualcomm deal.

A 44% stock implosion and a class-action lawsuit. How Fiserv's broken promises on innovation triggered a crisis and a warning for the FinTech industry.

A $15 million donation from Publix Charities confronts the Southeast's housing crisis, blending a legacy of giving with a critical modern-day need.

Junior miner Walker Lane Resources seeks a strategic partner after permitting woes stalled its 2025 plans. Can it unlock its Nevada gold potential?

As a £2.3B buyout of JTC plc looms, a hedge fund's growing bet via derivatives reveals the complex power plays governed by UK takeover transparency rules.

A strategic investment firm's move signals strong confidence in the closing of Avadel's multi-billion dollar deal, spotlighting its blockbuster sleep drug.

A routine UK regulatory filing from hedge fund Kite Lake Capital exposes a calculated short position on Qualcomm, hinting at a hidden M&A drama.

As AI adoption surges, it creates critical security blind spots. A burgeoning deep observability market, led by Gigamon, offers the essential solution.

A routine regulatory filing reveals First Trust's 4.99% stake in NCC Group, fueling speculation around the struggling cybersecurity firm's future.

A 1.26% stake in Just Group, held via derivatives by Balyasny, reveals a classic merger arbitrage strategy as Brookfield's £2.4bn acquisition nears.

A new oral drug could eliminate the dangerous side effects of CAR T-Cell therapy, potentially making the breakthrough cancer treatment safer and more accessible.